Inhalation by design: novel ultra-long-acting ?(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroup.

Source:http://linkedlifedata.com/resource/pubmed/id/20804199

J. Med. Chem. 2010 Sep 23 53 18 6640-52

Download in:

View as

General Info

PMID
20804199